The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users
Study identifier:D5040N00007
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users
Medical condition
Uncomplicated peptic ulcer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
39000
Study type
Observational
Age
50 Years - 84 Years
Date
Study Start Date: 01 Nov 2012
Primary Completion Date: 01 May 2013
Study Completion Date: 01 May 2013
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Patients with prescription for low dose ASA (75-300 mg/day) | - |
Contacts
Investigators
Principal Investigator
Luis A Garcia Rodriguez
CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )
